Quick answer
The core difference between at-home and in-clinic ketamine is monitoring. In-clinic treatment is delivered under direct medical supervision with vital-sign monitoring, while at-home programs typically use lower-dose sublingual lozenges with remote check-ins. In-clinic care offers tighter safety oversight and precise dosing, which matters most for higher-risk patients and stronger doses. At-home models prioritize convenience and access. The right choice depends on your medical risk, your diagnosis, and how much supervision your situation calls for.
If you are in crisis, call or text 988 for the Suicide and Crisis Lifeline, or call 911 for an emergency.
Is In-Clinic Ketamine Safer Than At-Home?
For most clinical purposes, in-clinic ketamine offers a higher level of safety because trained staff monitor your blood pressure, heart rate, and response throughout, and can intervene immediately if needed. This matters most with higher doses, with IV delivery, and for patients who have any medical risk factors. The supervised setting is built to catch and manage the uncommon problems that can arise.
At-home ketamine is not inherently unsafe for carefully selected, low-risk patients on low-dose lozenges, but it shifts more responsibility onto the patient and relies on remote oversight. The key question is not which is universally safer, but which level of monitoring your specific health profile requires, which is a clinical judgment. Our guide on whether ketamine therapy is right for you covers the candidacy factors that drive this.
Which Is More Effective?
Effectiveness depends more on accurate diagnosis, appropriate dosing, and consistent follow-up than on location alone, but the most robust evidence base is for supervised IV ketamine and clinic-administered esketamine. At-home lozenge programs are newer and generally use lower doses, so the depth of evidence is not yet equivalent. For treatment-resistant depression specifically, the supervised forms have the strongest track record. Our IV ketamine vs Spravato vs lozenges guide compares the forms directly.
That said, the best treatment is one you can actually access and stick with. For some people, a convenient at-home option that they complete consistently may serve them better than an in-clinic plan they cannot get to. This tradeoff is worth discussing honestly with a provider.
Who Is At-Home Ketamine Appropriate For?
At-home ketamine may be reasonable for lower-risk adults with no significant cardiovascular or psychiatric red flags, who can follow a structured protocol and stay in contact with their care team. It is generally not appropriate for people with uncontrolled blood pressure, psychosis or mania risk, substance misuse, or those who would benefit from the precise dosing and monitoring of IV treatment.
A proper candidacy evaluation is what separates a safe at-home candidate from someone who needs supervised care. Programs that skip a thorough medical and psychiatric screening are cutting the wrong corner.
What About Spravato Specifically?
Spravato (esketamine) cannot be used at home. Under its FDA safety program, it must be administered in a certified healthcare setting where you are monitored for a period after each dose. So if the insurance-eligible Spravato route fits your diagnosis, in-clinic care is the only option for it, by design.
Care at Ascend: Learn more about Ketamine Therapy at Ascend Mind and Body, or book an appointment.
Frequently asked questions
Is at-home ketamine legal?
Prescribed at-home ketamine, typically as sublingual lozenges through a supervising provider, operates within medical practice for appropriate patients. It still requires a prescription, a candidacy evaluation, and clinical oversight. Spravato specifically must be given in a certified clinical setting.
Why do clinics monitor vital signs during ketamine?
Ketamine can temporarily raise blood pressure and heart rate, so monitoring lets staff confirm you stay within a safe range and respond quickly if needed. This is one of the main safety advantages of in-clinic treatment.
Can I switch from at-home to in-clinic ketamine?
Often yes. If an at-home approach is not giving enough relief or your situation changes, a provider can reassess and recommend supervised IV treatment or Spravato. The forms are not mutually exclusive over the course of care.
Which is cheaper, at-home or in-clinic?
At-home lozenge programs are often less expensive per dose, while in-clinic IV sessions cost more because of the supervision involved. Spravato may be partly covered by insurance. Compare the full course cost, not just one session. See our ketamine therapy cost guide for the full picture.
Does Ascend offer at-home ketamine in Florida?
Ascend provides supervised, in-clinic ketamine sessions at its Wesley Chapel clinic rather than an at-home lozenge program, so that vital signs and dosing are monitored directly during each session. Whether supervised care is the right level for you is determined in a candidacy evaluation that reviews your medical and psychiatric risk.
Medically reviewed by
Anna Stouffer, PMHNP-BC
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- McIntyre RS, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression. American Journal of Psychiatry, 2021. https://pubmed.ncbi.nlm.nih.gov/33726522/
- U.S. Food and Drug Administration. FDA approves new nasal spray medication for treatment-resistant depression, available only at a certified doctor's office or clinic. https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified
- National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/topics/depression